STOCK TITAN

Warburg Pincus amendment: holds 11.2% of Sotera Health (NYSE: SHC)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Sotera Health Co ownership update: a group of Warburg Pincus entities reports an aggregate position of 31,838,253 shares of Common Stock, representing approximately 11.2% of outstanding shares. The filing states the percentage is calculated using 284,392,079 shares outstanding as of February 17, 2026.

The Warburg Pincus Reporting Persons say they are party to a Stockholders Agreement with GTCR and other holders; the GTCR Sponsors are publicly reported to own 12,735,301 shares per a Form 4 filed March 10, 2026. Each Warburg Pincus Reporting Person expressly disclaims beneficial ownership of shares held of record by the GTCR Sponsors except as set forth in the Stockholders Agreement.

Positive

  • None.

Negative

  • None.

Insights

Warburg Pincus entities disclose an 11.2% aggregate position and joint governance ties with GTCR.

The filing documents that the Warburg Pincus Reporting Persons collectively account for 31,838,253 shares, calculated on a base of 284,392,079 shares outstanding as of February 17, 2026. It also cites a Stockholders Agreement governing voting arrangements with the GTCR Sponsors and other holders.

The concrete items to watch in subsequent filings include any changes in reported beneficial ownership by GTCR (the filing cites 12,735,301 shares reported by GTCR on March 10, 2026) and any amendments to the Stockholders Agreement that could alter voting blocs or dispositive rights.

Filing emphasizes joint-filing group and explicit disclaimers of beneficial ownership tied to a Stockholders Agreement.

The Warburg Pincus Reporting Persons state they may be deemed a "group" under the Exchange Act and incorporate a joint filing agreement as Exhibit 99.1. The disclosure clarifies shared voting powers (31,838,253 votes) and shared dispositive power for 19,102,952 shares as reported on cover rows.

Relevant dependencies include the Stockholders Agreement terms and GTCR's separate reports; any future revisions to the agreement or to who holds dispositive power should appear in later amendments or Forms 4/13D filings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does Warburg Pincus report in Sotera Health (SHC)?

Warburg Pincus entities report holding 31,838,253 shares, about 11.2%. This percentage is calculated using 284,392,079 shares outstanding as of February 17, 2026, per the filing's cited prospectus.

How much ownership do GTCR Sponsors report in Sotera Health?

The filing cites GTCR's publicly reported ownership of 12,735,301 shares, referenced from a Form 4 filed on March 10, 2026. Warburg Pincus states that figure is GTCR's report, not Warburg Pincus's own ownership count.

Does Warburg Pincus claim control over GTCR-held shares?

No. The filing says Warburg Pincus may be deemed to beneficially own GTCR-held shares due to a Stockholders Agreement, but each Warburg Pincus Reporting Person expressly disclaims beneficial ownership of shares owned of record by GTCR except as recorded.

What voting and dispositive powers are disclosed by Warburg Pincus?

The cover-page figures show shared voting power of 31,838,253 shares and shared dispositive power of 19,102,952 shares for the Warburg Pincus Reporting Persons, as stated in Item 4 of the amendment.

On what basis were the percentages calculated?

Percentages are calculated using 284,392,079 shares outstanding as of February 17, 2026, cited from the Issuer's final prospectus on Form 424B7 filed March 5, 2026, per the filing's footnote.





03/06/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors (as defined in Item 2) are party to a Stockholders Agreement with the GTCR Investors (as defined in Item 4) and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the U.S. Securities and Exchange Commission ("Commission") on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person (as defined in Item 2). The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) As more fully described in Item 4 of this Amendment No. 5 to Schedule 13G, the WP Investors are party to a Stockholders Agreement with the GTCR Investors and certain other holders of Common Stock of the Issuer. The WP Investors, together with the GTCR Investors, hold an aggregate total of 31,838,253 shares of Common Stock of the Issuer (approximately 11.2% of the outstanding shares of Common Stock of the Issuer), of which 12,735,301 shares of Common Stock are publicly reported as being owned by the GTCR Investors in such entities' Form 4, filed with the Commission on March 10, 2026. Although the Warburg Pincus Reporting Persons may be deemed to beneficially own the Common Stock held as of record by the GTCR Investors as a result of the Stockholders Agreement, each Warburg Pincus Reporting Person expressly disclaims beneficial ownership (within the meaning of Rule 13d-3 of the Exchange Act with respect to any shares of Common Stock other than the shares of Common Stock of the Issuer owned of record by such Warburg Pincus Reporting Person. The percentages herein have been determined in accordance with footnote 2 below. Capitalized terms used herein are defined in Items 2(a) or 4 below. (2) Calculated based on 284,392,079 shares of Common Stock outstanding as of February 17, 2026 as reported on the Issuer's final prospectus reported on Form 424B7, filed on March 5, 2026.


SCHEDULE 13G



WARBURG PINCUS & CO.
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
WP XI Partners, L.P.
Signature:/s/ Warburg Pincus XI, L.P.
Name/Title:Warburg Pincus XI, L.P / General Partner
Date:03/10/2026
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II, L.P
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus Private Equity XI, L.P.
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti, Partner
Date:03/10/2026
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus XI Partners, L.P.
Signature:/s/ Warburg Pincus XI, L.P.
Name/Title:Warburg Pincus XI, L.P. / General Partner
Date:03/10/2026
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus Private Equity XI-B, L.P.
Signature:/s/ Warburg Pincus XI, L.P.
Name/Title:Warburg Pincus XI, L.P. / General Partner
Date:03/10/2026
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus Private Equity XI-C, L.P.
Signature:/s/ Warburg Pincus (Cayman) XI, L.P.
Name/Title:Warburg Pincus (Cayman) XI, L.P. / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus XI-C, LLC
Name/Title:Warburg Pincus XI-C, LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II (Cayman), L.P.
Name/Title:Warburg Pincus Partners II (Cayman), L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:03/10/2026
Bull Co-Invest L.P.
Signature:/s/ WP Bull Manager LLC
Name/Title:WP Bull Manager LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Warburg Pincus XI, L.P.
Signature:/s/ WP Global LLC
Name/Title:WP Global LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
WP Global LLC
Signature:/s/ Warburg Pincus Partners II, L.P.
Name/Title:Warburg Pincus Partners II, L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus Partners II, L.P.
Signature:/s/ Warburg Pincus Partners GP LLC
Name/Title:Warburg Pincus Partners GP LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus Partners GP LLC
Signature:/s/ Warburg Pincus & Co.
Name/Title:Warburg Pincus & Co. / Managing Member
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Partner
Date:03/10/2026
Warburg Pincus (Cayman) XI, L.P.
Signature:/s/ Warburg Pincus XI-C, LLC
Name/Title:Warburg Pincus XI-C, LLC / General Partner
Date:03/10/2026
Signature:/s/ Warburg Pincus Partners II (Cayman), L.P.
Name/Title:Warburg Pincus Partners II (Cayman), L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:03/10/2026
Warburg Pincus XI-C, LLC
Signature:/s/ Warburg Pincus Partners II (Cayman), L.P.
Name/Title:Warburg Pincus Partners II (Cayman), L.P. / Managing Member
Date:03/10/2026
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:03/10/2026
Warburg Pincus Partners II (Cayman), L.P.
Signature:/s/ Warburg Pincus (Bermuda) Private Equity GP Ltd.
Name/Title:Warburg Pincus (Bermuda) Private Equity GP Ltd. / General Partner
Date:03/10/2026
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:03/10/2026
Warburg Pincus (Bermuda) Private Equity GP Ltd.
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Authorised Signatory
Date:03/10/2026
Warburg Pincus LLC
Signature:/s/ Harsha Marti
Name/Title:Harsha Marti / Managing Director, Chief Legal Officer and Head of New Solutions
Date:03/10/2026
Exhibit Information

Exhibit 99.1 Agreement of Joint Filing as required by Rule 13d-1(k)(1) under the Act.* * Incorporated herein by reference to the Agreement of Joint Filing by Warburg Pincus Private Equity XI, L.P., Warburg Pincus XI Partners, L.P., Warburg Pincus Private Equity XI-B, L.P., WP XI Partners, L.P., Warburg Pincus Private Equity XI-C, L.P., Bull Co-Invest L.P., Warburg Pincus XI, L.P., WP Global LLC, Warburg Pincus Partners II, L.P., Warburg Pincus Partners GP LLC, Warburg Pincus & Co., Warburg Pincus (Cayman) XI, L.P., Warburg Pincus XI-C, LLC, Warburg Pincus Partners II (Cayman), L.P., Warburg Pincus (Bermuda) Private Equity GP LTD., and Warburg Pincus LLC ("Warburg Pincus Funds") dated as of February 14, 2022, which was previously filed with the Commission as Exhibit 99.1 to Amendment No. 1 to Schedule 13G filed by the Warburg Pincus Funds on February 14, 2022 with respect to the shares of common stock of Sotera Health Co.